You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Pediatric Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-grade Glioma, Solid Tumor, Unspecified, Child Trial in Edison (2-OHOA)

Recruiting
  • High-grade Glioma
  • Solid Tumor, Unspecified, Child
  • Edison, New Jersey
    Hackensack Meridian Health, Inc
Aug 16, 2022

Advanced Cancer, Metastatic Solid Tumor Trial in New York (Repotrectinib, Irinotecan and temozolomide)

Recruiting
  • Advanced Cancer
  • Metastatic Solid Tumor
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Dec 1, 2022

Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies Trial in Worldwide (Durvalumab / Tremelimumab Combination

Active, not recruiting
  • Pediatric Cancer
  • +2 more
  • Durvalumab / Tremelimumab Combination Therapy
  • Baltimore, Maryland
  • +18 more
Nov 3, 2022

Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)

Completed
Has Results
  • Hodgkin Disease
  • Brentuximab vedotin
  • +3 more
  • Aurora, Colorado
  • +13 more
Jun 17, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

Recruiting
  • Locally Advanced Solid Tumors
  • +3 more
  • Oral repotrectinib (TPX-0005)
  • Los Angeles, California
  • +27 more
Aug 9, 2022

Cancer of the Prostate Trial in United States (BHR-200 (0.36% transdermal 17ß-estradiol gel), Placebo)

Terminated
Has Results
  • Cancer of the Prostate
  • BHR-200 (0.36% transdermal 17β-estradiol gel)
  • Placebo
  • Tucson, Arizona
  • +11 more
Mar 8, 2022

Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • Palo Alto, California
  • +9 more
Aug 2, 2022

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • San Francisco, California
  • +35 more
May 25, 2022

SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination

Active, not recruiting
  • SARS-CoV Infection
  • Covid19
  • SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
  • +5 more
  • Birmingham, Alabama
  • +155 more
Dec 16, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Atopic Dermatitis, Open Label Trial in United States (Ruxolitinib cream)

Active, not recruiting
  • Atopic Dermatitis
  • Open Label
  • Ruxolitinib cream
  • Gilbert, Arizona
  • +14 more
Jul 29, 2022

Solid Tumor, Leukemia Trial in Paris (Solid tumor and CT DNA)

Recruiting
  • Solid Tumor
  • Leukemia
  • Solid tumor and CT DNA
  • Paris, Villejuif, France
    Gustave Roussy
Jan 19, 2023

To Determine the Cumulative Incidence of AKI Using KDIGO Criteria in Pediatric Patients With Malignancy in South Egypt Cancer

Not yet recruiting
  • To Determine the Cumulative Incidence of AKI Using KDIGO Criteria in Pediatric Patients With Malignancy in South Egypt Cancer Institute (SECI)
  • kidney function test
  • (no location specified)
Oct 7, 2023

Locally Advanced Rectal Cancer Trial in Spain, United States (Peposertib 50 mg, Peposertib 100 mg, Peposertib 150 mg)

Completed
Has Results
  • Locally Advanced Rectal Cancer
  • Peposertib 50 mg
  • +5 more
  • Aurora, Colorado
  • +13 more
Jun 9, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Orange, California
  • +38 more
Aug 24, 2022

Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))

Recruiting
  • Solid Tumors Harboring NTRK Fusion
  • Larotrectinib (Vitrakvi, BAY2757556)
  • Los Angeles, California
  • +50 more
Jan 29, 2023

Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

Recruiting
  • Malignant Glioma
  • High Grade Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +4 more
  • Birmingham, Alabama
  • +2 more
Feb 2, 2023

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Neuroblastoma Trial in United States (Ceritinib, dasatinib, sorafenib)

Recruiting
  • Neuroblastoma
  • Birmingham, Alabama
  • +23 more
Sep 26, 2022

Pediatric Cancer Trial in Ann Arbor (Cognitive Compensatory Training)

Recruiting
  • Pediatric Cancer
  • Cognitive Compensatory Training
  • Ann Arbor, Michigan
    University of Michigan
Jan 19, 2023

Cardiovascular Assessment of Pediatric Cancer Survivors

Completed
  • Left Ventricular Dysfunction
  • Heart Failure
  • ECG, Echocardiography, cTnI, NT-ProBNP
  • Fatih, Istanbul, Turkey
    Istanbul Faculty of Medicine
Jul 8, 2023

Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +118 more
Jan 27, 2023

Pediatric Physical Activity for Children With Cancer

Completed
  • Pediatric Cancer
  • Physical Activity
  • Physical Activity
  • Honolulu, Hawaii
  • +2 more
Aug 25, 2023

Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +108 more
Oct 19, 2022

Weight, Body Trial in Chicago (Time restircted eating, Time restricted eating + prebiotic, Control)

Not yet recruiting
  • Weight, Body
  • Time restircted eating
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 21, 2023